{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:16:47Z","timestamp":1775017007420,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41440-020-0434-0","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T06:02:26Z","timestamp":1586757746000},"page":"884-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pentraxin-3 is a candidate biomarker on the spectrum of severity from pre-eclampsia to HELLP syndrome: GenPE study"],"prefix":"10.1038","volume":"43","author":[{"given":"Claudia C.","family":"Colmenares-Mej\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris C.","family":"Quintero-Lesmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula K.","family":"Bautista-Ni\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Guio Mahecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Beltr\u00e1n Avenda\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Alfonso","family":"D\u00edaz Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Ortiz Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Carolina","family":"P\u00e1ez Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Monterrosa Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara Maria","family":"Mesa Restrepo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germ\u00e1n","family":"Monsalve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"San\u00edn-Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilmar","family":"Saldarriaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Lucrecia","family":"Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan P.","family":"Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma","family":"Serrano D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,13]]},"reference":[{"key":"434_CR1","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0140-6736(06)69380-X","volume":"368","author":"C Ronsmans","year":"2006","unstructured":"Ronsmans C, Graham WJ. Maternal mortality: who, when, where, and why. Lancet. 2006;368:1189\u2013200.","journal-title":"Lancet."},{"key":"434_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","volume":"367","author":"KS Khan","year":"2006","unstructured":"Khan KS, Wojdyla D, Say L, G\u00fclmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066\u201374.","journal-title":"Lancet"},{"key":"434_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","volume":"170","author":"E Abalos","year":"2013","unstructured":"Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol. 2013;170:1\u20137.","journal-title":"Eur J Obstet Gynecol"},{"key":"434_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785\u201399.","journal-title":"Lancet."},{"key":"434_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"R Levine","year":"2004","unstructured":"Levine R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Ph D. Circulating angiogenic factors and the risk of preeclampsia. N. Engl J Med. 2004;350:672\u201383.","journal-title":"N. Engl J Med"},{"key":"434_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.siny.2006.04.001","volume":"11","author":"AM Borzychowski","year":"2006","unstructured":"Borzychowski AM, Sargent IL, Redman CWG. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006;11:309\u201316.","journal-title":"Semin Fetal Neonatal Med"},{"key":"434_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","volume":"23","author":"C Garlanda","year":"2005","unstructured":"Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005;23:337\u201366.","journal-title":"Annu Rev Immunol"},{"key":"434_CR8","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1182\/blood.V84.10.3483.3483","volume":"84","author":"VV Alles","year":"1994","unstructured":"Alles VV, Bottazzi B, Peri G, Golay J, Introna M, Mantovani A. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood. 1994;84:3483\u201393.","journal-title":"Blood"},{"key":"434_CR9","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1002\/eji.200324390","volume":"33","author":"A Doni","year":"2003","unstructured":"Doni A, Peri G, Chieppa M, Allavena P, Pasqualini F, Vago L, et al. Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells. Eur J Immunol. 2003;33:2886\u201393.","journal-title":"Eur J Immunol"},{"key":"434_CR10","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/00003246-200107000-00017","volume":"29","author":"B Muller","year":"2001","unstructured":"Muller B, Peri G, Doni A, Torri V, Landmann R, Bottazzi B, et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med. 2001;29:1404\u20137.","journal-title":"Crit Care Med"},{"key":"434_CR11","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1002\/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6","volume":"44","author":"F Fazzini","year":"2001","unstructured":"Fazzini F, Peri G, Doni A, Dell\u2019Antonio G, Dal Cin E, Bozzolo E, et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum. 2001;44:2841\u201350.","journal-title":"Arthritis Rheum"},{"key":"434_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/ATVBAHA.108.178947","volume":"29","author":"NS Jenny","year":"2009","unstructured":"Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty BM. Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 2009;29:594\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"434_CR13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00011-012-0507-x","volume":"61","author":"P Zhou","year":"2012","unstructured":"Zhou P, Luo X, Qi H-B, Zong W-J, Zhang H, Liu D-D, et al. The expression of pentraxin 3 and tumor necrosis factor-alpha is increased in preeclamptic placental tissue and maternal serum. Inflamm Res. 2012;61:1005\u201312.","journal-title":"Inflamm Res"},{"key":"434_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1095\/biolreprod.107.062414","volume":"77","author":"S Tranguch","year":"2007","unstructured":"Tranguch S, Chakrabarty A, Guo Y, Wang H, Dey SK. Maternal pentraxin 3 deficiency compromises implantation in mice. Biol Reprod. 2007;77:425\u201332.","journal-title":"Biol Reprod"},{"key":"434_CR15","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.ajog.2005.11.018","volume":"3","author":"I Cetin","year":"2006","unstructured":"Cetin I, Cozzi V, Pasqualini F, Nebuloni M, Garlanda C, Scd V, et al. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2006;3:1347\u201353.","journal-title":"Am J Obstet Gynecol"},{"key":"434_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/01.AOG.0000224607.46622.bc","volume":"108","author":"P Rovere-Querini","year":"2006","unstructured":"Rovere-Querini P, Antonacci S, Antonio GD, Angeli A. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol. 2006;108:148\u201355.","journal-title":"Obstet Gynecol"},{"key":"434_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.preghy.2018.03.005","volume":"14","author":"P Garg","year":"2018","unstructured":"Garg P, Kumar A, Kachhawa G, Kumar K. Estimation of asymmetric dimethylarginine (ADMA), placental growth factor (PLGF) and pentraxin 3 (PTX 3) in women with preeclampsia. Pregnancy Hypertens. 2018;14:245\u201351.","journal-title":"Pregnancy Hypertens."},{"key":"434_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","volume":"103","author":"BM Sibai","year":"2004","unstructured":"Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103:981\u201391.","journal-title":"Obstet Gynecol"},{"key":"434_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.clp.2004.06.008","volume":"31","author":"JR Barton","year":"2004","unstructured":"Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol. 2004;31:807\u201333.","journal-title":"Clin Perinatol"},{"key":"434_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.preghy.2012.01.001","volume":"2","author":"JM Roberts","year":"2012","unstructured":"Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens. 2012;2:72\u201383.","journal-title":"Pregnancy Hypertens"},{"key":"434_CR21","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.placenta.2012.09.009","volume":"33","author":"V Cozzi","year":"2012","unstructured":"Cozzi V, Garlanda C, Nebuloni M, Maina V, Martinelli A, Calabrese S, et al. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR. Placenta. 2012;33:1039\u201344.","journal-title":"Placenta."},{"key":"434_CR22","unstructured":"Estudio de Genes Candidatos en Preeclampsia. 2005. Disponible en: www.genpe.org"},{"key":"434_CR23","doi-asserted-by":"crossref","unstructured":"National High Blood Pressure Education Program. \u201cReport of the national high blood pressure education program working group on high blood pressure in pregnancy\u201d. Am J Obstet Gynecol. 2000;183:s1\u201322.","DOI":"10.1067\/mob.2000.107928"},{"key":"434_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0002-9378(90)90376-I","volume":"162","author":"BM Sibai","year":"1990","unstructured":"Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol. 1990;162:311\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"434_CR25","unstructured":"Departamento Administrativo Nacional de Estad\u00edstica. Estratificaci\u00f3n Socioecon\u00f3mica. 2019. Disponible en: https:\/\/www.dane.gov.co\/files\/geoestadistica\/Preguntas_frecuentes_estratificacion.pdf."},{"key":"434_CR26","unstructured":"GenPE. Recruitment questionaire. 2010. Disponible en: http:\/\/www.genpe.org\/\/index.php?option=com_content&task=view&id=41&Itemid=26."},{"key":"434_CR27","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/hr.2016.41","volume":"39","author":"TG Papaioannou","year":"2016","unstructured":"Papaioannou TG, Protogerou AD, Vrachatis D, Konstantonis G, Aissopou E, Argyris A, et al. Mean arterial pressure values calculated using seven different methods and their associations with target organ deterioration in a single-center study of 1878 individuals. Hypertens Res. 2016;39:640\u20137.","journal-title":"Hypertens Res"},{"key":"434_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.vph.2006.08.011","volume":"45","author":"A Mantovani","year":"2006","unstructured":"Mantovani A, Garlanda C, Bottazzi B, Peri G, Doni A, Martinez Y. et al. The long pentraxin PTX3 in vascular pathology. Vascul Pharmacol. 2006;45:326\u201330.","journal-title":"Vascul Pharmacol."},{"key":"434_CR29","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/01.CIR.102.6.636","volume":"102","author":"G Peri","year":"2000","unstructured":"Peri G, Introna M, Corradi D, Iacuitti G, Signorini S, Pizzetti F, et al. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation. 2000;102:636\u201341.","journal-title":"Circulation"},{"key":"434_CR30","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1161\/01.CIR.0000145167.30987.2E","volume":"110","author":"R Latini","year":"2004","unstructured":"Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation. 2004;110:2349\u201354.","journal-title":"Circulation"},{"key":"434_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12979-019-0144-0","volume":"16","author":"A Carrizzo","year":"2019","unstructured":"Carrizzo A, Procaccini C, Lenzi P, Fusco C, Villa F, Migliarino S, et al. PTX3: An inflammatory protein modulating ultrastructure and bioenergetics of human endothelial cells. Immun Ageing. 2019;16:3\u20137.","journal-title":"Immun Ageing"},{"key":"434_CR32","doi-asserted-by":"publisher","first-page":"e63493","DOI":"10.1371\/journal.pone.0063493","volume":"8","author":"A Witasp","year":"2013","unstructured":"Witasp A, Ryd\u00e9n M, Carrero JJ, Qureshi AR, Nordfors L, N\u00e4slund E, et al. Elevated circulating levels and tissue expression of Pentraxin 3 in uremia: a reflection of endothelial dysfunction. PLoS ONE. 2013;8:e63493.","journal-title":"PLoS ONE"},{"key":"434_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12979-016-0080-1","volume":"13","author":"F Fornai","year":"2016","unstructured":"Fornai F, Carrizzo A, Forte M, Ambrosio M, Damato A, Ferrucci M, et al. The inflammatory protein Pentraxin 3 in cardiovascular disease. Immun Ageing. 2016;13:1\u20139.","journal-title":"Immun Ageing"},{"key":"434_CR34","first-page":"2505","volume":"86","author":"DF Benyo","year":"2014","unstructured":"Benyo DF, Smarason A, Redman CWG, Sims C, Conrad KP, Obstetrics D, et al. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 2014;86:2505\u201312.","journal-title":"J Clin Endocrinol Metab"},{"key":"434_CR35","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0002-9378(99)70325-X","volume":"181","author":"BK Rinehart","year":"1999","unstructured":"Rinehart BK, Terrone DA, Lagoo-deenadayalan S, William H, Hale EA, Martin JN, et al. Expression of the placental cytokines tumor necrosis factor \u03b1, interleukin 1 \u03b2, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol. 1999;181:915\u201320.","journal-title":"Am J Obstet Gynecol"},{"key":"434_CR36","first-page":"601","volume":"328","author":"G Pardi","year":"1993","unstructured":"Pardi G. Diagnostic value of blood sampling in fetuses with growth retardation. Fetal Diagn Ther. 1993;328:601\u20132.","journal-title":"Fetal Diagn Ther"},{"key":"434_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/10641955.2017.1321016","volume":"36","author":"HA Cakmak","year":"2017","unstructured":"Cakmak HA, Cakmak BD, Yayla CA, Coskun I, Erturk M, Keles I. Hypertension in Pregnancy Assessment of relationships between novel inflammatory markers and presence and severity of preeclampsia: epicardial fat thickness, pentraxin-3, and neutrophil-to-lymphocyte ratio. Hypertens Pregnancy. 2017;36:233\u20139.","journal-title":"Hypertens Pregnancy"},{"key":"434_CR38","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/pd.2311","volume":"29","author":"R Akolekar","year":"2009","unstructured":"Akolekar R, Casagrandi D, Livanos P, Tetteh A, Nicolaides KH. Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn. 2009;29:934\u20138.","journal-title":"Prenat Diagn."},{"key":"434_CR39","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/00016340902971441","volume":"88","author":"I Cetin","year":"2009","unstructured":"Cetin I, Cozzi V, Papageorghiou AT, Maina V, Montanelli A, Garlanda C, et al. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction. Acta Obstet Gynecol Scand. 2009;88:846\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"434_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1742-7622-2-11","volume":"2","author":"M H\u00f6fler","year":"2005","unstructured":"H\u00f6fler M. The Bradford Hill considerations on causality: a counterfactual perspective? Emerg Themes Epidemiol. 2005;2:11.","journal-title":"Emerg Themes Epidemiol"},{"key":"434_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41440-018-0092-7","volume":"42","author":"K Furuya","year":"2019","unstructured":"Furuya K, Kumasawa K, Nakamura H, Nishimori K, Kimura T. Novel biomarker profiles in experimental aged maternal mice with hypertensive disorders of pregnancy. Hypertens Res. 2019;42:29\u201339.","journal-title":"Hypertens Res"},{"key":"434_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1600-0412.2011.01238.x","volume":"91","author":"RR Hamad","year":"2012","unstructured":"Hamad RR, Eriksson MJ, Berg E, Larsson A, Bremme K. Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia. Acta Obstet Gynecol Scand. 2012;91:50\u20136.","journal-title":"Acta Obstet Gynecol Scand."}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-0434-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-0434-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-0434-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:24:16Z","timestamp":1684617856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-020-0434-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,13]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["434"],"URL":"https:\/\/doi.org\/10.1038\/s41440-020-0434-0","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,13]]},"assertion":[{"value":"3 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}